AHA Scientific Sessions 2018
Omega-3 fatty acids (found in fish oil supplements) were not associated with a reduction in cardiovascular (CV) events ...
Koen Ameloot, MD, PhD discussed the Neuroprotect trial, which looked at 112 survivors of out-of-hospital cardiac arrest ...
In this interview, Jafna L. Cox, MD, talks with DocWire News about the results of the IMPACT-AF study, and about the ...
Sotirios Tsimikas, MD, of the University of California San Diego, talks with DocWire News about experimental agents that ...
Peter McCartney, MD, a cardiology research Fellow at Golden Jubilee National Hospital in the United Kingdom, talks with ...
Anticoagulation prescription for preventing stroke in patients with atrial fibrillation (AF) got a boost with the use of ...
Christopher Cannon, MD, of Harvard Medical School, talks with DocWire News about the American Diabetes Association ...
Jafna Layth Cox, MD, of the Queen Elizabeth II Health Sciences Ctr in Halifax, Nova Scotia, Canada, talks with DocWire ...
Dorairaj Prabhakaran, MD, DM, of the Centre for Chronic Disease Control in New Delhi, India, talks with DocWire News ...
JoAnne Manson, MD, of Harvard Medical School in Boston, talks with DocWire News about the recently presented VITAL trial ...
Barry H. Greenberg, MD, of the University of California, San Diego, talks with DocWire News about his presentation of a ...
Subodh Verma, MD, of St. Michael's Hospital and University of Toronto, talks with DocWire News about the EMPA-HEART ...
Stephen D. Wiviott, MD, talks with DocWire News, about the results and implications from the Dapagliflozin Effect on ...
DocWire News recently caught up with distinguished interventional cardiologist Peter Block, MD, at the American Heart ...
An online computerized decision support system had no effect on the number of patients experiencing an unplanned ...
Heribert Schunkert, MD, of the German Heart Center in Munich, Germany, talks with DocWire News about the TiCAB trial ...
Alert-based computerized decision support was associated with a significantly increased rate of anticoagulation ...
Empagliflozin, an SGLT2 inhibitor, significantly reversed left ventricular (LV) remodeling in a population of diabetic ...
Yoga-based cardiac rehabilitation following myocardial infarction was not associated with a reduction in cardiovascular ...
Vitamin D supplementation, as well as omega-3 fatty acid supplementation, were not associated with a significant ...
Christopher Cannon, MD, Professor of Medicine at Harvard Medical School, talks with DocWire News about the new American ...
Eric J. Velazquez, MD, Robert W. Berliner Professor of Cardiology and Chief of the Section of cardiovascular medicine in ...
Here are several late-breaking trials from DocWire News’ coverage of the American Heart Association's 2018 ...
Ticagrelor monotherapy did not yield an additional benefit for cardiovascular events or in terms of bleeding compared to ...
Dapagliflozin neither increased nor decreased major adverse cardiovascular events (MACE), but did reduce other adverse ...
In patients on statin therapy with established cardiovascular disease (CVD) who also have elevated cholesterol and ...
In patients with hemodynamically stabilized acute heart failure with reduced ejection fraction (HFrEF), a combination ...
Personalized risk assessments and new cholesterol-lowering therapies were among the new key recommendation of the ...
Advertisement
Advertisement
